<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cho Y</submitter><funding>National Research Foundation of Korea</funding><pagination>322</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12576987</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Coactivator-associated arginine methyltransferase 1 (CARM1) regulates diverse cellular processes-including transcription, cell cycle progression, metabolism, and autophagy-through asymmetric dimethylation of both histone and non-histone substrates. Although TP-064 and EZM2302 both inhibit CARM1, they may elicit distinct biological effects.&lt;h4>Methods&lt;/h4>We employed immunoblotting, subcellular fractionation, histone extraction, chromatin immunoprecipitation assay, quantitative PCR, and confocal microscopy to compare the effects of TP-064 and EZM2302. Substrate methylation and autophagic responses were evaluated under nutrient-deprived conditions.&lt;h4>Results&lt;/h4>Both TP-064 and EZM2302 inhibited CARM1-dependent methylation of non-histone substrates, including p300, GAPDH,</pubmed_abstract><journal>Molecular medicine (Cambridge, Mass.)</journal><pubmed_title>Context-specific applications of CARM1 inhibitors: functional profiles of EZM2302 and TP-064.</pubmed_title><pmcid>PMC12576987</pmcid><funding_grant_id>RS-2025-00563180</funding_grant_id><funding_grant_id>RS-2024-00412728</funding_grant_id><pubmed_authors>Cho Y</pubmed_authors><pubmed_authors>Kim YK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Context-specific applications of CARM1 inhibitors: functional profiles of EZM2302 and TP-064.</name><description>&lt;h4>Background&lt;/h4>Coactivator-associated arginine methyltransferase 1 (CARM1) regulates diverse cellular processes-including transcription, cell cycle progression, metabolism, and autophagy-through asymmetric dimethylation of both histone and non-histone substrates. Although TP-064 and EZM2302 both inhibit CARM1, they may elicit distinct biological effects.&lt;h4>Methods&lt;/h4>We employed immunoblotting, subcellular fractionation, histone extraction, chromatin immunoprecipitation assay, quantitative PCR, and confocal microscopy to compare the effects of TP-064 and EZM2302. Substrate methylation and autophagic responses were evaluated under nutrient-deprived conditions.&lt;h4>Results&lt;/h4>Both TP-064 and EZM2302 inhibited CARM1-dependent methylation of non-histone substrates, including p300, GAPDH,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T10:34:12.613Z</modification><creation>2026-05-16T03:08:03.245Z</creation></dates><accession>S-EPMC12576987</accession><cross_references><pubmed>41174476</pubmed><doi>10.1186/s10020-025-01388-y</doi></cross_references></HashMap>